“… while India has been polio-free for a year, there has been a huge increase in non-polio acute flaccid paralysis (NPAFP). Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received”.
The polio vaccine contain a synthetic polio virus and not the wild polio virus found in nature. In 2011 polio vaccine with its synthetic laboratory made virus was the cause of 47,500 new cases of what they call non-polio acute flaccid paralysis NPAFP. Excerpts from the Indian Journal follows:
Synthetic polio makes eradication impossible
The charade about polio eradication and the great savings it will bring has persisted to date. It is a paradox, that while the director general of WHO, Margret Chan, and Bill Gates are trying to muster support for polio eradication (22) it has been known to the scientific community, for over 10 years, that eradication of polio is impossible.
The elephant in the room: the problem of non-polio Acute Flaccid Paralysis (AFP)
It has been reported in the Lancet that the incidence of AFP, especially non-polio AFP has increased exponentially in India after a high potency polio vaccine was introduced (25)
National Polio Surveillance Project shows that the non-polio AFP rate increases in proportion to the number of polio vaccine doses received in each area. Nationally, the non-polio AFP rate is now 12 times higher than expected.
From India’s perspective the exercise has been extremely costly both in terms of human suffering and in monetary terms. It is tempting to speculate what could have been achieved if the $2.5 billion spent on attempting to eradicate polio were spent on water and sanitation and routine immunization.
Conclusion
The polio eradication programme epitomises nearly everything that is wrong with donor funded ‘disease specific’ vertical projects, at the cost of investments in community-oriented primary health care (horizontal programmes)(38). http://www.issuesinmedicalethics.org/202co114.html
Read the study
A new vaccine for influenza has hit the market, and it is the first ever to contain genetically-modified (GM) proteins derived from insect cells. According to reports, the U.S. Food and Drug Administration (FDA) recently approved the vaccine, known as Flublok, in January 2013, which contains recombinant DNA technology and an insect virus known as baculovirus that is purported to help facilitate the more rapid production of vaccines. read more…
